` 688247 (Sinotherapeutics Inc) vs Shanghai Composite Comparison - Alpha Spread

S
688247
vs
S
Shanghai Composite

Over the past 12 months, Sinotherapeutics Inc has underperformed Shanghai Composite, delivering a return of -6% compared to the Shanghai Composite's +23% growth.

Stocks Performance
688247 vs Shanghai Composite

Loading
688247
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688247 vs Shanghai Composite

Performance Gap Between 688247 and SSEC
HIDDEN
Show

Performance By Year
688247 vs Shanghai Composite

Loading
688247
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sinotherapeutics Inc vs Peers

Shanghai Composite
688247
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sinotherapeutics Inc
Glance View

Market Cap
4.6B CNY
Industry
Pharmaceuticals

Sinotherapeutics, Inc. engages in the research and development, production and sales of high-end generic drugs and Contract Research Organization (CRO) services. The company is headquartered in Shanghai, Shanghai and currently employs 248 full-time employees. The company went IPO on 2022-08-25. The firm's main businesses include research and development, production and sales of generic drugs, as well as contract research and development organization (CRO) services. The firm mainly operates in the domestic market and overseas markets.

Sinotherapeutics Inc Intrinsic Value
HIDDEN
Show
Back to Top